KEGG   DRUG: PegloticaseHelp
Entry
D09316                      Drug                                   

Name
Pegloticase (USAN/INN);
Krystexxa (TN)
Product
Formula
C1549H2430N408O448S8
Exact mass
34171.7673
Mol weight
34192.8533
Source
Sus scrofa [TAX:9823]
Remark
ATC code: M04AX02
Product: D09316<US>
Efficacy
Gout suppressant
  Disease
Chronic gout [DS:H01532]
Comment
Pegloticase is PEG-recombinant uricase [EC:1.7.3.3]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 M MUSCULO-SKELETAL SYSTEM
  M04 ANTIGOUT PREPARATIONS
   M04A ANTIGOUT PREPARATIONS
    M04AX Other antigout preparations
     M04AX02 Pegloticase
      D09316  Pegloticase (USAN/INN) <US>
Drug classes of therapeutic agents [br08360.html]
 Antirheumatic and antigout agents
  D09316
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D09316
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09316
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and germline mutations
  D09316
BRITE hierarchy
Other DBs
CAS: 885051-90-1
PubChem: 96025996
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system